☆ 4.8 Article

Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab

FRONTIERS IN IMMUNOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma

Toni K. Choueiri et al.

Summary: In this phase 3 trial, treatment with cabozantinib in combination with nivolumab and ipilimumab showed significantly longer progression-free survival in previously untreated advanced renal-cell carcinoma patients, compared to treatment with nivolumab and ipilimumab alone. Although 43% of patients in the experimental group had a response, grade 3 or 4 adverse events were more common in this group.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

添加到收藏夹

Review Urology & Nephrology

The Emerging Role of Extracranial Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma: A Systematic Review

Jennifer Le Guevelou et al.

Summary: Stereotactic ablative radiotherapy (SABR) has potential in the management of metastatic renal cell carcinoma (mRCC) as a part of multimodal approaches. SABR can achieve complete remission of metastatic lesions, prolong the duration of systemic therapy, improve treatment response in polymetastatic patients, and reduce tumor burden in some cases. The impact on renal function is unclear. Overall, the combination of SABR and systemic agents is well-tolerated.

EUROPEAN UROLOGY FOCUS (2023)

添加到收藏夹

Article Immunology

Shikonin inhibits immune checkpoint PD-L1 expression on macrophage in sepsis by modulating PKM2

Lijia Yuan et al.

Summary: This study evaluated the effects of Shikonin on modulating PD-L1 expression and its interaction with PKM2. The results showed that Shikonin significantly reduced the levels of inflammatory cytokines in sepsis mice, maintained the percentage of T cells, and decreased splenocyte apoptosis. Additionally, Shikonin attenuated PD-L1 expression on macrophages by downregulating phosphorylation and nuclear import of PKM2. Further research is needed to assess the clinical significance of Shikonin in regulating PD-L1 by targeting PKM2.

INTERNATIONAL IMMUNOPHARMACOLOGY (2023)

添加到收藏夹

Article Oncology

Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway

Sascha D. Markowitsch et al.

Summary: This study evaluated the impact of shikonin (SHI) from traditional Chinese medicine on therapy-sensitive and therapy-resistant renal cell carcinoma (RCC) cells. The results showed that SHI could inhibit the growth of RCC cells and block cell division. SHI also induced cell death and inhibited a key pathway for cell survival and growth. Therefore, SHI may be a potential option for treating RCC.

CANCERS (2022)

添加到收藏夹

Article Oncology

Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy

Jeffrey Graham et al.

Summary: This study found that first-line immune checkpoint inhibitor (ICI) treatment appears to be associated with improved overall survival (OS) compared to VEGF and mTOR targeted therapy in patients with advanced non-clear cell renal cell carcinoma (nccRCC).

EUROPEAN JOURNAL OF CANCER (2022)

添加到收藏夹

Review Cell Biology

Ectopic Tumor VCAM-1 Expression in Cancer Metastasis and Therapy Resistance

Kristen A. A. VanHeyst et al.

Summary: Vascular Cell Adhesion Molecule-1 (VCAM-1) is a membrane protein with critical physiological functions in cellular immune response. It can be cleaved into a soluble form (sVCAM-1) and elevated concentrations of sVCAM-1 have been found in the peripheral blood of cancer patients. The VCAM-1/VLA-4 signaling plays a vital role in tumor metastasis and therapy resistance.

CELLS (2022)

添加到收藏夹

Article Oncology

Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapy

Simon Heumos et al.

Summary: This study identified specific cell surface receptor biomarkers for colon and renal cancer through analyzing the surface receptors of tumor cells, with CD106 (VCAM1) identified as a promising novel immunotherapeutic target for renal cancer treatment.

CANCER CELL INTERNATIONAL (2022)

添加到收藏夹

Article Oncology

Identification of EZH2 as Cancer Stem Cell Marker in Clear Cell Renal Cell Carcinoma and the Anti-Tumor Effect of Epigallocatechin-3-Gallate (EGCG)

Chen Lyu et al.

Summary: Cancer stem cells play a crucial role in renal cell carcinoma, and a potential treatment strategy to suppress these cells has been identified, along with the identification of related markers.

CANCERS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Big Five Pphytochemicals Targetingn Cancer Stem Cells: Curcumin, EGCG, Sulforapphanen, Resveratrol and Genistein

Cord Naujokat et al.

Summary: Cancer stem cells (CSCs) possess resistance mechanisms to current cancer therapies and pathways for survival. Certain phytochemicals can interfere with these pathways and eliminate CSCs, offering a potential novel therapeutic strategy against cancer.

CURRENT MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Review Oncology

Dietary Phytochemicals as a Potential Source for Targeting Cancer Stem Cells

Prasath Manogaran et al.

Summary: Cancer stem cells play a crucial role in tumor initiation and progression, exhibiting resistance to conventional therapy, while natural products may provide an effective approach to eradicate these cells.

CANCER INVESTIGATION (2021)

添加到收藏夹

Article Medicine, General & Internal

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

T. K. Choueiri et al.

Summary: The study demonstrates that nivolumab plus cabozantinib has significant advantages over sunitinib in the treatment of previously untreated advanced renal-cell carcinoma, including progression-free survival, overall survival, and likelihood of response.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Robert Motzer et al.

Summary: The study demonstrated that the combination of lenvatinib with pembrolizumab led to significantly longer progression-free survival and overall survival than sunitinib, while the combination of lenvatinib with everolimus showed longer progression-free survival but not overall survival compared to sunitinib. Adverse events were more frequent in patients receiving lenvatinib-based treatments.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Shikonin Induced Program Cell Death through Generation of Reactive Oxygen Species in Renal Cancer Cells

Ming-Feng Tsai et al.

Summary: The study found that shikonin induced programmed cell death in renal cancer cells by increasing ROS levels and p38 activity, while also promoting autophagy. N-acetyl cysteine can alleviate shikonin-induced cell death and ROS generation.

ANTIOXIDANTS (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

A novel Apigenin derivative suppresses renal cell carcinoma via directly inhibiting wild-type and mutant MET

Jing Li et al.

Summary: Compound 15e shows potential as a treatment for renal cell carcinoma by inhibiting MET activation and overcoming drug resistance.

BIOCHEMICAL PHARMACOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Understanding Lung Carcinogenesis from a Morphostatic Perspective: Prevention and Therapeutic Potential of Phytochemicals for Targeting Cancer Stem Cells

Win Sen Heng et al.

Summary: Lung cancer, one of the deadliest cancers, can be effectively reduced through prevention measures, though treatment improvements are still needed to address therapeutic resistance caused by cancer stem cells; phytochemicals in plant-based diets are believed to have efficacy in targeting lung cancer stem cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Nanoscience & Nanotechnology

The Synergistic Anticancer Effect of Dual Drug- (Cisplatin/Epigallocatechin Gallate) Loaded Gelatin Nanoparticles for Lung Cancer Treatment

Yin-Ju Chen et al.

JOURNAL OF NANOMATERIALS (2020)

添加到收藏夹

Review Urology & Nephrology

Epidemiology of Renal Cell Carcinoma

Umberto Capitanio et al.

EUROPEAN UROLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Brian I. Rini et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1

Hairui Wang et al.

NANO LETTERS (2019)

添加到收藏夹

Review Oncology

Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy

Plabon K. Das et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2019)

添加到收藏夹

Article Immunology

Icaritin promotes tumor T-cell infiltration and induces antitumor immunity in mice

Haibang Hao et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2019)

添加到收藏夹

Review Nutrition & Dietetics

Tea Polyphenols in Promotion of Human Health

Naghma Khan et al.

NUTRIENTS (2019)

添加到收藏夹

Article Medicine, General & Internal

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

R. J. Motzer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas

Arezoo Rasti et al.

SCIENTIFIC REPORTS (2018)

添加到收藏夹

Review Pathology

Biomarker discovery for renal cancer stem cells

Claudia Corro et al.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2018)

添加到收藏夹

Review Urology & Nephrology

Targeted therapies for renal cell carcinoma

Edwin M. Posadas et al.

NATURE REVIEWS NEPHROLOGY (2017)

添加到收藏夹

Article Cell Biology

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

Pornpimol Charoentong et al.

CELL REPORTS (2017)

添加到收藏夹

Article Oncology

Deubiquitination and Stabilization of PD-L1 by CSN5

Seung-Oe Lim et al.

CANCER CELL (2016)

添加到收藏夹

Article Oncology

VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma

Xinqi Wu et al.

CANCER IMMUNOLOGY RESEARCH (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem Cells

Zhi-xiang Yuan et al.

FRONTIERS IN PHARMACOLOGY (2016)

添加到收藏夹

Review Cell & Tissue Engineering

Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells

Mohammed I. Khan et al.

STEM CELL RESEARCH & THERAPY (2015)

添加到收藏夹

Article Cell & Tissue Engineering

CXC Chemokine Receptor 4 is Essential for Maintenance of Renal Cell Carcinoma-Initiating Cells and Predicts Metastasis

Maximilian Gassenmaier et al.

STEM CELLS (2013)

添加到收藏夹

Article Oncology

Regorafenib (BAY 73-4506): Stromal and Oncogenic Multikinase Inhibitor with Potential Activity in Renal Cell Carcinoma

Kamarul Zaki et al.

CURRENT ONCOLOGY REPORTS (2013)

添加到收藏夹

Review Biochemistry & Molecular Biology

The cancer stem cell: premises, promises and challenges

Hans Clevers

NATURE MEDICINE (2011)

添加到收藏夹

Review Oncology

The role of vascular cell adhesion molecule-1 in tumor immune evasion

T-C. Wu

CANCER RESEARCH (2007)

添加到收藏夹

Article Oncology

Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients

Ko-ichi Shioi et al.

CLINICAL CANCER RESEARCH (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.